BrainStorm Cell Therapeutics (OTCBB:BCLI) Has Potentially Developed A Treatment For ALS

Monday, January 30, 2012 - 17:00 in Health & Medicine

Last week a U.S. company announced initial Phase I/II clinical trial results for ALS (Amyotrophic Lateral Sclerosis).

Read the whole article on Newswise - Scinews

Get the latest and most popular science news articles of the week in your Inbox! It's free!